IE57767B1 - A process for obtaining cell cultures - Google Patents
A process for obtaining cell culturesInfo
- Publication number
- IE57767B1 IE57767B1 IE932/85A IE93285A IE57767B1 IE 57767 B1 IE57767 B1 IE 57767B1 IE 932/85 A IE932/85 A IE 932/85A IE 93285 A IE93285 A IE 93285A IE 57767 B1 IE57767 B1 IE 57767B1
- Authority
- IE
- Ireland
- Prior art keywords
- cultures
- kidneys
- cell
- cells
- cell cultures
- Prior art date
Links
- 238000004113 cell culture Methods 0.000 title claims abstract description 20
- 238000000034 method Methods 0.000 title claims description 26
- 210000003734 kidney Anatomy 0.000 claims abstract description 22
- 210000003292 kidney cell Anatomy 0.000 claims description 17
- 241000282887 Suidae Species 0.000 claims description 14
- 102000029816 Collagenase Human genes 0.000 claims description 7
- 108060005980 Collagenase Proteins 0.000 claims description 7
- 229960002424 collagenase Drugs 0.000 claims description 7
- 102000004190 Enzymes Human genes 0.000 claims description 3
- 108090000790 Enzymes Proteins 0.000 claims description 3
- 229940088598 enzyme Drugs 0.000 claims description 3
- 241000700605 Viruses Species 0.000 abstract description 17
- 102000035195 Peptidases Human genes 0.000 abstract 1
- 108091005804 Peptidases Proteins 0.000 abstract 1
- 230000029087 digestion Effects 0.000 abstract 1
- 235000019833 protease Nutrition 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 19
- 102000004142 Trypsin Human genes 0.000 description 5
- 108090000631 Trypsin Proteins 0.000 description 5
- 230000000394 mitotic effect Effects 0.000 description 5
- 239000012588 trypsin Substances 0.000 description 5
- 239000002953 phosphate buffered saline Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 239000000725 suspension Substances 0.000 description 3
- 241000702263 Reovirus sp. Species 0.000 description 2
- 241000031091 Synodontis clarias Species 0.000 description 2
- 206010000210 abortion Diseases 0.000 description 2
- 231100000176 abortion Toxicity 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 244000309466 calf Species 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 238000003306 harvesting Methods 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 210000001161 mammalian embryo Anatomy 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000000644 propagated effect Effects 0.000 description 2
- 239000013049 sediment Substances 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 229960005486 vaccine Drugs 0.000 description 2
- 241000282693 Cercopithecidae Species 0.000 description 1
- 239000006145 Eagle's minimal essential medium Substances 0.000 description 1
- 241000193159 Hathewaya histolytica Species 0.000 description 1
- 241000204031 Mycoplasma Species 0.000 description 1
- 241000125945 Protoparvovirus Species 0.000 description 1
- 235000015107 ale Nutrition 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000035931 haemagglutination Effects 0.000 description 1
- 239000000413 hydrolysate Substances 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 239000012679 serum free medium Substances 0.000 description 1
- 208000002254 stillbirth Diseases 0.000 description 1
- 231100000537 stillbirth Toxicity 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 241001529453 unidentified herpesvirus Species 0.000 description 1
- 210000003501 vero cell Anatomy 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0684—Cells of the urinary tract or kidneys
- C12N5/0686—Kidney cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12051—Methods of production or purification of viral material
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Chemical And Physical Treatments For Wood And The Like (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The cell cultures are obtained from the kidneys of pig carcasses by digestion with a proteinase. Cell cultures of this type can be used advantageously for growing viruses.
Description
Processes for the preparation of cell cultures, including those of pig kidneys, for obtaining virus sus5 pensions as vaccine antigens are known. They are based, for example, on the use of pig embryo kidneys, piglet kidneys, permanent pig kidney cell lines or kidneys from slaughtered pigs.
The disadvantages of the processes of the state of the art for industrial production are: pig embryo kidneys are not obtainable in adequate quantity and at the desired times for production on the industrial scale. Piglet kidneys are relatively small, which means that, while the cell growth is good, the resulting cell yield is only low. In addition, as a rule, the carcass from which these kidneys have been removed cannot be used as a foodstuff. Although permanent pig kidney cell lines, such as PK 15, IBRS 2, 3TA or SK 6, can be propagated in large amounts, they are frequently contaminated with foreign agents, such as mycoplasma or viruses, so that their industrial utilisation for the preparation of immuno biological products entails increased risk. Moreover, the effort associated w i t h maintaining the cell line, including the continuous checks of quality, is considerable.
An additional factor is that many viruses do not multiply on permanent cell lines, because of their genetic changes, or they multiply only poorly compared with primary cultures of organ cells.
Kidneys from slaughtered pigs are a favorable basis for cells in terms of cost However, compared with embryonal or piglet kidneys, kidneys from slaughtered adult pigs result in only relatively few cells having mitotic activity. If, moreover, kidneys from slaughtered pigs are disintegrated in the conventional manner using the digestive enzyme trypsin, which damages cells, there is a further drastic reduction in the number of vital cells in a cell culture thus set up. It is evident from ) this that suspensions of kidney cells from slaughtered pigs which have been disintegrated by fermentation in the conventional Banner lead only with considerable effort, such as by changing the medium, increased addition of serum to the culture medium or special culture me di a, and after a long culture time, to cell cultures, which are only partially complete in most cases.
Thus, there are difficulties in respect of the readiness to grow of cultures of kidney cells from slaugh10 tered pigs which have been prepared by the customary trypsin disintegration of the organs. In particular, these difficulties with growth emerge when the culture vessels containing the kidney cells from slaughtered pigs which have been disintegrated by trypsin are rolled for optimal utilization of the culture surface.
Thus, there has continued to be a requirement for a process, which is also industrially satisfactory, for obtaining cultures of pig kidney cells.
Surprisingly, & process permits kidney cells from si augh dense cell cultures without special and without changing the medium, stationary or rolled cultures, the use of collagenase solution neys to give single cells. has now been found which tered pigs to grow to a d d ΐ t i ves to the me di um i n 5 to 8 days in This process comprises to disintegrate the kidThus the invention relates to a process for obtaining a cell culture by disintegration of kidneys of slaughtered pigs using an enzyme, wherein the enzyme is collage n a s e, from, used i A collagenase which can be used can be obtained ;or example, Clostridium histolyticum, and it is ; a concentration of 10-15, preferably 12.5, mg (corresponding to 6,,250 Mandi units) per 100 ml o‘ phosphate-buffered saline (PBS, pH 7.0 to 7.5).
It is particularly important in order to obtain large amounts of vital single cells having mitotic activity to expose the comminuted kidneys to the collagenase solution for a period of 12 to 24 hours, while agitating at 16 to 220C . are then purified Tne single cells thus obtained in a known manner by centrifugation at about 800 x g and washing with PBS. The centrifuged cell sediment is subsequently resuspended in the ratio of, preferably,, 1:250 to 1 :350 in known culture media,, such ©s Eagles minimal essential medium (E a ales HER) or in T C R 199 with the addi· tion of 100 ml/l calf ss um, and divided into portions in culture vessels which are kept stationary^ or are rolled,, at 37°C. Hany of the kidney cells sedimented on the glass surface start to divide within 3 to 16 hours. This process cen be observed under a microscope and it shows that there is a significant difference in the number of kidney cells which ire a ble to divide,, and in the speed of the sequence of cell division,, compared with batches of cells using conventional culture processes. The mitotic activity of the pig kidney cells treated with collagenase rapidly leads to dense growth of the cell cultures without any additional auxiliary measures for fhe cell culture.
By this aeans, it is possible, as illustrated in the examples which follow, advantageously to prepare, in rapid sequence, large amounts of cell cultures for the industrial culturing of viruses.
Example 1 Kidneys from slaughtered pigs were disintegrated to give single cells by the conventional process using 2 g/l trypsin solution, centrifuged at about 800 x g, washed with PBS and again centrifuged. The cell sediment was suspended in the ratio 1:300 in Eagles HER, to which 2.5 g/1 I acta I bumin hydrolysate (LAH) and 100 ml/l calf serum had been added. 600 ml quantities of this suspension were placed in sterile 5 I glass flasks. tures were incubated at 3 7°C, tially complete cell cultures had formed within 10 to 14 days, After changing iVue^edi um to serum-free medium (Eagles MEH with 2.5 g/ 1 LAH), the cultures were infected wifh reoT h e cul· while rolling. Only parvirus of serotypes 1 and 3, and kept 37°C for 3 to 5 The days until the culture was ready for harvesting, virus content of the harvested cultures tested, after removal of the cell residues by centrifugation followed by filtration, in the customary manner by inoculation of serial dilutions onto cell cultures.
For comparison, sterile, comminuted kidneys of slaughtered pigs were treated with collagenase solution which contained 12.5 mg of collagenase per I (corresponding to 6,250 Mandi units/100 ml)- After exposure for a period of 18 hours at 18°C, the kidney cells which had been disintegrated into single cells were further processed r I I, in the sai manner as betors The culture media- the cuI· ture vessels, the quantities of cell suspensions placed therein, and th® incubation were the same, in contrast to the cell cultures by the conventional process, mitoses of the kidney cells disintegrated by the process according to the invention were detectable under a microscope after only a few hour: Moreover, the individual cells with :o one mother, since mitotic activity were very close the number of damaged, and thus amitotic, cells was greatly reduced compared with the conventional disintegration process- Because the mitotic processes started very early 20 and were very numerous, densely closed tissue cultures which were capable of infection were present 5 to, at the most, 8 days after setting up the cell culture. The infection of th® tissue cultures ©nd the harvesting and testing of the viruses were carried out in a manner ana25 logous to that for the cultures prepared by the conventional process5 culture batches were prepared on the industrial seel® by each of the two processes described, snd 150 to I 300 I of reovirus of serotypes 1 and 3 were cultured on 30 each of these. The virus contents of the comparison batches were determined on permanent monkey kidney cells (vero cells). The titers found with the process according to the invention in place of the process of the state of the art were up to 14-5 times higher for reovirus of sero35 type 3, ©nd 5-6 to 6-3 times higher for serotype 1,.
Example 2 To prepare 40 I of a suspension of rhinopneumonitis virus (cause of abortion in mares) on piglet kidney cells, young piglets were necessary, while only two pairs of I - 6 kidneys from slaughtered pigs are used in the process, according to the invention, of Example 1. Wo deficiency in the quality of the virus prepared by the process according to the invention was observed» Example 3 As a herpes virus, the Aujeszky virus is a poor antigen, for which reason it is very important to have a high virus content in the vaccine. Comparison cultures of Aujeszky virus were carried out on cultures of kidneys from slaughtered pigs which had been prepared, on the one hand, by the conventional process using kidney cells disintegrated with trypsin and, on the other hand, by the process according to the invention (Example 1). While the virus titer/ml for the cultures prepared by the conventional process was 10"^ *5 z £ he mean for the cultures prepared by the process according to the invention was 10o,?z which means that the virus synthesized by the tissue cultures, which were younger (5-8 days old) and dense, was about ten times that synthesized by the cultures of the state of the art, which were older (10-14 days old) and, as a rule, not dense.
Example 4 Pig parvovirus (PPV) is regarded as the cause of the SMEDI syndrome in breeding sows, the characteristics of which are abortion, stillbirths, birth of piglets of low viability, and sterility in sows. PPV multiplies only in young cultures of pig tissue which are still growing, preferably in pig kidney cultures. Trials of the cultivation of PPV in cultures, prepared by the process according to the invention, tissue from slaughtered Dias have shown that cell cultures of this type are particularly well suited for the propagation of this virus. Hemagglutination titers of from 1:2048 to 1:16,384 were found, while virus titers of only 1:1024 are regarded as being good for PPV propagated according to the state of the art in embryonal pig kidney cell cultures or permanent pig kidney lines. itatmur)
Claims (3)
1. A process for obtaining a cell culture by disintegration of the kidneys of slaughtered pigs using en enzyme, which comprises exposing the comminuted kidneys 5 to a stirred collagenase solution with a concentration of 100-150 mg/1 for 12 to 24 hours at IS to 22 fl C and allowing the pig kidney cells obtained in this way to grow to cell cultures in a known manner.
2. A process as claimed in claim 1, substantially 10 as hereinbefore described and exemplified.
3. A cell culture whenever obtained by a process claimed in a preceding claim. F. R. KELLY & CO. AGENTS FOR THE APPLICANTS
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19843413960 DE3413960A1 (en) | 1984-04-13 | 1984-04-13 | METHOD FOR OBTAINING CELL CULTURES |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE850932L IE850932L (en) | 1985-10-13 |
| IE57767B1 true IE57767B1 (en) | 1993-04-07 |
Family
ID=6233485
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE932/85A IE57767B1 (en) | 1984-04-13 | 1985-04-12 | A process for obtaining cell cultures |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP0158285B1 (en) |
| AT (1) | ATE61815T1 (en) |
| DE (2) | DE3413960A1 (en) |
| DK (1) | DK171576B1 (en) |
| ES (1) | ES8603568A1 (en) |
| IE (1) | IE57767B1 (en) |
| PT (1) | PT80265B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2126832C1 (en) * | 1997-11-28 | 1999-02-27 | Открытое акционерное общество "СПб-Технология" | Method of cell culture preparing |
| DE102009022916B4 (en) * | 2009-05-27 | 2011-05-19 | Dst Dauermagnet-System Technik Gmbh | Magnetic coupling and containment shell for a magnetic coupling |
| RU2412994C1 (en) * | 2010-01-20 | 2011-02-27 | ФГУП "Всероссийский научно-исследовательский институт рыбного хозяйства и океанографии" (ВНИРО) | Method of obtaining culture of pacific salmon cells |
-
1984
- 1984-04-13 DE DE19843413960 patent/DE3413960A1/en not_active Withdrawn
-
1985
- 1985-04-04 AT AT85104102T patent/ATE61815T1/en not_active IP Right Cessation
- 1985-04-04 DE DE8585104102T patent/DE3582186D1/en not_active Expired - Lifetime
- 1985-04-04 EP EP85104102A patent/EP0158285B1/en not_active Expired - Lifetime
- 1985-04-11 ES ES542143A patent/ES8603568A1/en not_active Expired
- 1985-04-11 PT PT80265A patent/PT80265B/en not_active IP Right Cessation
- 1985-04-12 DK DK167685A patent/DK171576B1/en not_active IP Right Cessation
- 1985-04-12 IE IE932/85A patent/IE57767B1/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DK167685D0 (en) | 1985-04-12 |
| PT80265A (en) | 1985-05-01 |
| ES542143A0 (en) | 1985-12-16 |
| PT80265B (en) | 1987-09-30 |
| IE850932L (en) | 1985-10-13 |
| ES8603568A1 (en) | 1985-12-16 |
| DE3413960A1 (en) | 1985-10-17 |
| DE3582186D1 (en) | 1991-04-25 |
| DK167685A (en) | 1985-10-14 |
| EP0158285A3 (en) | 1987-10-21 |
| EP0158285A2 (en) | 1985-10-16 |
| EP0158285B1 (en) | 1991-03-20 |
| DK171576B1 (en) | 1997-01-20 |
| ATE61815T1 (en) | 1991-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Aaronson et al. | Nonproducer clones of murine sarcoma virus transformed BALB3T3 cells | |
| Philipson et al. | Molecular biology of adenoviruses | |
| KR101835100B1 (en) | Method for culturing adherent cells | |
| JP2011212021A (en) | Method for producing active constituent of pharmaceutical or diagnostic agent in mdck cell suspension culture | |
| CZ261796A3 (en) | Vaccine for prevention respiratory and reproduction diseases of pigs | |
| US6783983B1 (en) | Methods for cultivating cells and propagating viruses | |
| Hunter | [32] Biological techniques for avian sarcoma viruses | |
| US5550051A (en) | Avian embryo cell aggregate biomass for producing virus/virus antigen and method for producing virus/virus antigen | |
| CA1093995A (en) | Rapid propagation of sv3t3 cells for production of mif and taf | |
| JPS6150599B2 (en) | ||
| US3520972A (en) | Feline virus vaccines obtained by propagation and serial passage attenuation of virulent feline viruses in diploid feline embryo tissue cell serial passage subculture strains | |
| US3887430A (en) | Culture medium for tissue culture techniques | |
| CA1092038A (en) | Diploid porcine embryonic cell strains, cultures produced therefrom and use of said cultures for production of vaccines | |
| EP0981601A1 (en) | Methods for cultivating cells and propagating viruses | |
| Vonka et al. | Some properties of the soluble (S) antigen of cultured lymphoblastoid cell lines | |
| US4169761A (en) | Process for the cultivation of viruses | |
| IE57767B1 (en) | A process for obtaining cell cultures | |
| US4055466A (en) | Culture medium for tissue culture techniques | |
| Andresen et al. | Characterization and spontaneous neoplastic transformation of mouse embryo cells isolated and continuously cultured in vitro in chemically defined medium NCTC 135 | |
| CN109943521A (en) | A kind of intestine of young pigs epithelial cell fast preparation method suitable for Porcine epidemic diarrhea virus culture | |
| Webber | Effects of serum on the growth of prostatic cells in vitro | |
| Della-Porta et al. | An experimental inactivated virus vaccine against bovine ephemeral fever 1. Studies of the virus | |
| Greig | Continuous cultivation and susceptibility to bovine viruses of cell lines derived from bovine embryonic tissues | |
| CA1215335A (en) | Tissue culture medium | |
| Li et al. | A Method for Tissue Culture of Hydra Cells. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Patent lapsed |